← Back to Search

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy for Anxiety and Depression in Autism

N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial looks at how CBT therapy can help autistic youth with anxiety or depression.

Who is the study for?
This trial is for autistic adolescents aged 12-17 with significant anxiety and/or depression, based in Texas. They must have a diagnosis of autism confirmed by specific assessments and primary issues with anxiety or depression. A parent must participate, no current psychotherapy for these conditions, stable medication use, and sufficient English skills are required.Check my eligibility
What is being tested?
The study is examining the impact of transdiagnostic cognitive behavioral therapy (CBT) on autistic youth with anxiety or depression compared to usual treatment methods. It aims to see if this tailored CBT approach can effectively reduce symptoms across both conditions.See study design
What are the potential side effects?
Since the intervention involves therapy sessions rather than medication, typical side effects associated with drugs are not expected. However, participants may experience emotional discomfort or distress as they confront challenging thoughts and feelings during therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Global Impression - Improvement
Clinical Global Impression - Severity of Illness
Revised Children's Anxiety and Depression Scale - Parent-Report
Secondary outcome measures
Children's Depression Rating Scale, Revised
Pediatric Anxiety Rating Scale modified for Autism
Revised Children's Anxiety and Depression Scale - Self-Report

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Transdiagnostic cognitive behavioral therapyExperimental Treatment1 Intervention
Group II: Treatment as usualActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,300 Total Patients Enrolled
28 Trials studying Depression
5,547 Patients Enrolled for Depression
Texas Higher Education Coordinating BoardUNKNOWN
2 Previous Clinical Trials
195 Total Patients Enrolled

Media Library

Transdiagnostic Cognitive Behavioral Therapy (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05738967 — N/A
Depression Research Study Groups: Transdiagnostic cognitive behavioral therapy, Treatment as usual
Depression Clinical Trial 2023: Transdiagnostic Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT05738967 — N/A
Transdiagnostic Cognitive Behavioral Therapy (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05738967 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation open to adults of eighteen years or older in this clinical experiment?

"The prerequisites for entry into this research trial necessitates that applicants be between the ages of 12 and 17. In comparison, 328 studies are available to those under 18 years old while 1,268 exist for subjects over 65."

Answered by AI

Does this medical experiment seek any new participants presently?

"According to clinicaltrials.gov, this research study is currently looking for participants; the trial was initially published on March 15th 2023 and most recently revisited on March 22nd of the same year."

Answered by AI

To what extent is participation in this study widespread?

"Affirmative. The clinical trial registry on clinicaltrials.gov reveals that this study is currently recruiting for participants as of March 22nd, 2023 and was initially published on the 15th of March, 2023. There are 112 individuals needed to be recruited at a single medical centre."

Answered by AI

What criteria are needed to qualify for this experiment?

"This clinical study is seeking 112 minors between the ages of 12 and 17 who are suffering from anxiety. For eligibility, they must meet criteria for autism spectrum disorder according to evidence-based assessment metrics (e.g., Autism Diagnostic Observation Schedule-Second Edition; Childhood Autism Rating Scale-Second Edition). The child's symptoms should also be clinically significant with elevated scores on applicable rating scales (>11/ >39 respectively), a parent or guardian must agree to participate in this trial, both parties need basic English literacy skills, reside within Texas' borders and ultimately be deemed as having anxiety/depressive disorder being their primary presenting problem by an administration"

Answered by AI
~56 spots leftby May 2025